You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Lymphocytic Leukemia with deletion of the short arm of chromosome 17

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

Completed
  • Leukemia, Lymphocytic, Chronic
  • Dresden, Germany
  • +10 more
Jan 13, 2023

Leukemia, Leukemia, Lymphocytyc, CLL (Chronic Lymphocytic Leukemia) Trial run by the NHLBI (PCI 32765)

Active, not recruiting
Has Results
  • Leukemia
  • +3 more
  • PCI 32765
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021

Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

Completed
  • Loss of Chromosome 17p
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

Completed
  • Chronic Lymphocytic Leukemia
    • Calgary, Alberta, Canada
    • +12 more
    Jul 7, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • Tempe, Arizona
    • +14 more
    Jan 12, 2022

    Chronic Lymphocytic Leukemia, Loss of Chromosome 17p Trial (Ibrutinib, Venetoclax)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • Loss of Chromosome 17p
    • (no location specified)
    Oct 29, 2021

    Chronic Lymphocytic Leukemia Trial (Zebutinib&BR or Zebutinib&FCR)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Zebutinib&BR or Zebutinib&FCR
    • (no location specified)
    Jul 27, 2021

    Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • +2 more
    • ABT-199 (Main Cohort)
    • ABT-199 (Safety Expansion Cohort)
    • Tucson, Arizona
    • +47 more
    Nov 19, 2021

    Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Bad Saarow, Germany
    • +29 more
    May 4, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Louisville, Kentucky
    • +66 more
    Nov 9, 2022

    Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    • Tucson, Arizona
    • +40 more
    Dec 20, 2022

    CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

    Terminated
    Has Results
    • CLL
    • SLL
    • Boston, Massachusetts
    • +1 more
    Jan 30, 2023

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    Untreated Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Rituximab, Chlorambucil)

    Recruiting
    • Untreated Chronic Lymphocytic Leukemia
    • Beijing, China
    • +50 more
    Sep 26, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine Phosphate, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • La Plata, Buenos Aires, Argentina
    • +32 more
    Feb 10, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
    • +2 more
    Mar 16, 2022

    Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)

    Active, not recruiting
    • Anemia
    • +2 more
    • Birmingham, Alabama
    • +795 more
    Jan 28, 2023

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Obinutuzumab
    • +3 more
    • Birmingham, Alabama
    • +484 more
    Aug 24, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

    Active, not recruiting
    Has Results
    • Stage I Chronic Lymphocytic Leukemia
    • +3 more
    • Scottsdale, Arizona
    • +363 more
    Dec 30, 2022

    Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

    Active, not recruiting
    Has Results
    • Small Lymphocytic Lymphoma
    • CLL (Chronic Lymphocytic Leukemia)
    • Fludarabine Phosphate
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 13, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Mantle Cell Lymphoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 22, 2022